Company: ATHE
Filing Date: 2025-08-29
Form Type: 20-F
Source: 0001213900-25-082027
Chunk: 54

Company: ALTERITY THERAPEUTICS LTD
Filing Date: 2025-08-29
Form: 20-F
Item: Item 4
Chunk 54
---
 the bioMUSE natural history study:

●   July 2025 – Annals of Clinical and Translational Neurology, Title: “The MSA Atrophy Index (MSA-AI): An Imaging
                       Marker for Diagnosis and Clinical Progression in Multiple System Atrophy                   
------------------------------------------------------------------------------------------------------------------

●   May 2025 – International MSA Congress, Title: “MSA Atrophy Index (MSA-AI): A Quantitative Imaging Marker for Diagnosis
                                          and Monitoring of Multiple System Atrophy”                                      
--------------------------------------------------------------------------------------------------------------------------

●   May 2025 – International MSA Congress, Title: “Cutaneous Phosphorylated Alpha-Synuclein Deposition Informs Autonomic Function
                                       in Individuals with Early-Stage Multiple System Atrophy”                                  
---------------------------------------------------------------------------------------------------------------------------------

●   November 2024 - International Symposium on the Autonomic Nervous System, Title: “The MSA Atrophy Index: A Marker of Clinical
                                              Progression in Multiple System Atrophy”                                           
--------------------------------------------------------------------------------------------------------------------------------

●   September 2024 - International Congress of Parkinson’s Disease and Movement Disorders (MDS), Title: “Association Between
       Clinical Progression in Multiple System Atrophy and Brain Volume Changes Evaluated via Deep Learning Segmentation”   
----------------------------------------------------------------------------------------------------------------------------

●   April 2024 – American Academy of Neurology (AAN), Title: “Neurofilament Light Chain and Clinical Progression in Early
                                                   Multiple System Atrophy”                                              
-------------------------------------------------------------------------------------------------------------------------

●   November 2023 – American Autonomic Society (AAS) 34th International Symposium on the Autonomic Nervous System, Title: “Relationship
                            between N-acetylaspartate and neurofilament light chain in multiple system atrophy”                        
---------------------------------------------------------------------------------------------------------------------------------------

●            August 2023 – International Congress of Parkinson’s Disease and Movement Disorders (MDS), Titles: “A multimodal          
    approach for diagnosis of early Multiple System Atrophy”; “Preliminary evidence for evolution of myoinositol and N-acetylaspartate
                                as biomarkers of disease severity in early-stage Multiple System Atrophy”                             
--------------------------------------------------------------------------------------------------------------------------------------

●   April 2023 - American Neurological Association, Title: “Wearable Sensors for Quantitative Motor Assessments in MSA”
-----------------------------------------------------------------------------------------------------------------------

●   November 2022 - American Autonomic Society, Title: “Urinary symptom profile in early Multiple System Atrophy”
-----------------------------------------------------------------------------------------------------------------

●   October 2022 - American Neurological Association, Title: